13 July 2026
13 July 2026
The collaboration initially focuses on tuberculosis research in Thailand, where Fosun has identified customer interest.
The interim analysis included 426 participants aged one year and above.
The decisions are based on findings from the Phase III KEYNOTE-B15 trial.
The first patient was enrolled at Piedmont Heart Institute in Atlanta, Georgia, US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
